With its small population, highly digitized universal health system, and rapid, military-assisted vaccine rollout, Israel’s real-world data provides a useful supplement to clinical trials for researchers, pharmaceutical companies and policymakers.
The UK health secretary, Matt Hancock, has welcomed a new study that suggests one dose of the Oxford/AstraZeneca vaccine may reduce transmission of coronavirus by two-thirds. Hancock said the results of the trial backed up Britain’s strategy to delay the administering of the second dose of the vaccine by 12 weeks.
Hancock added: ‘We may well need boosters that have a slightly adjusted vaccine as well in the same way that we do for flu each year.’
New age group eligible from Thursday while focus remains on older at-risk people
Israel’s health ministry has said it will offer coronavirus vaccines to anyone over the age of 16, as part of a rapid campaign that has already seen the majority of older and vulnerable populations receive shots.
The ministry has told healthcare providers they can start booking appointments for the new age group starting on Thursday.
Brutal crackdown on protesters by riot police follows opposition leader’s 32-month prison sentence
The Kremlin has attempted to play down the jailing of the opposition leader Alexei Navalny, saying that his 32-month imprisonment will have not have “significant influence” on Russian politics or lead to a mass protest movement similar to the one in neighbouring Belarus.
Meanwhile, protesters detained at recent rallies in support of Navalny have complained of inhumane conditions as police hold them in overcrowded jails or on buses in subzero temperatures days after their arrest.
Agentes de la Policía Nacional y del Servicio Secreto de los Estados Unidos han llevado a cabo la mayor investigación de ámbito internacional realizada hasta la fecha contra el fraude cometido con tarjetas bancarias. Esta organización criminal creaba empresas ficticias en Estados Unidos con identidades falsas e ingresaban dinero desde España.
Visto en: https://www.youtube.com/europapress